Patent Yard Sign in
Canadian application, no grantCanada

Methods for detecting ovarian cancer

CA 2463920 A1 · Owner: Diamandis, Eleftherios · Inventors: Diamandis, Eleftherios; Yousef, George M.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Methods for diagnosing and monitoring ovarian carcinoma in a subject are described comprising measuring KLK9 or hK9 in a sample from the subject. The invention also provides localization or imaging methods for ovarian cancer and kits for carrying out the methods of the invention. The invention also contemplates therapeutic applications for ovarian cancer employing hK9 proteins, nucleic acid molecules encoding the proteins and/or binding agents , for the proteins.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 16, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 16, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 16, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 16, 2002
GrantedNo grant recorded
Term endedOctober 16, 2022
Patent numberCA 2463920 A1
Classification (IPC)—

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedOct 16, 2002Term endedOct 16, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.